![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Roches Actemra/RoActemra receives U.S. FDA EUA for the treatment of COVID-19 in hospitalised adults and children
Roche announced that the U.S. FDA has issued an EUA for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric...
Drug Research
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku
Fujitsu Japan Limited announced that it will initiate a new research project with a research team led by Takefumi Yamashita, Project Associate Professor of...
Drug Research
Coriolis Pharma Expands ATMP Development Facilities
Coriolis Pharma, a provider of research and development of for (bio)pharmaceutical drugs, is expanding its advanced therapy medicinal products (ATMP) development facilities under biosafety...
Drug Research
UNC researchers develop potential universal coronavirus vaccine
Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against...
Drug Research
mCureX and Samyang sign MoU for mRNA vaccine development
OliX Pharmaceuticals’ subsidiary mCureX has entered a memorandum of understanding (MoU) with Samyang Holdings to develop a messenger ribonucleic acid (mRNA) vaccine for Covid-19.
The...
Drug Research
AGC Biologics Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with BioNTech SE to further supply Plasmid DNA...
Drug Research
Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access ADUHELM
Following today’s U.S. FDA accelerated approval of ADUHELMTM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read